title: Do drospirenone-containing oral contraceptives have a higher risk of VTE?
authors.affiliation: Pace University PA Program, New York City, USA.
authors.forename: Jennifer Hofmann
authors.initials: JH
authors.lastname: Ribowsky
mesh_terms: D000328:Adult; D000736:Androstenes / Q000009:adverse effects*; D003276:Contraceptives, Oral / Q000009:adverse effects*; D004997:Ethinyl Estradiol / Q000009:adverse effects*; D005260:Female; D006801:Humans; D000451:Mineralocorticoid Receptor Antagonists / Q000009:adverse effects*; D054556:Venous Thromboembolism / Q000453:epidemiology*
chemical_list: D000736:Androstenes; D003276:Contraceptives, Oral; D000451:Mineralocorticoid Receptor Antagonists; C534342:drospirenone and ethinyl estradiol combination; D004997:Ethinyl Estradiol; C035144:drospirenone